![]() |
IQV | Iqvia Holdings Inc. |
Services-Commercial Physical & Biological Research |
Book value per $ invested | $ 0.52 |
Leverage | 77.66% |
Market Cap | $ 35.1B |
PE | 26.41 |
Dividend Yield | 0.00% |
Profit | $ 1.3B |
Margin | 8.55% |
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.